MOLECULAR TEMPLATES

Molecular Templates is a clinical-stage biopharmaceutical company focused on the discovery and development of the next generation of immunotoxins called engineered toxin bodies (ETBs) which are a novel class of therapeutics with unique biology and a differentiated mechanism of action. ETBs are targeted, are designed to induce their own internalization, even against non-internalizing receptors, and destroy tumor cells that are resistant to other modalities. ETBs have been well-tolerated in the clinic to date and show predictable pharmacokinetic and pharmacodynamic effects... At Molecular Templates, we are developing a pipeline of ETBs that we believe will provide meaningful benefit to patients. ETBs targeting some of the most important receptors in cancer are currently in clinical trials.

Also known as: Molecular Templates, Inc.

Primary location: Austin United States